Pursuant to Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, Marksans Pharma has informed that it enclosed disclosure in Form C made by Arvind Singh, an employee of the Company with respect to his sale of equity shares of the company.
The above information is a part of company’s filings submitted to BSE.